Arcutis Biother Rg
Arcutis Biotherapeutics develops dermatology drugs; lead product ZORYVE (roflumilast cream) cleared Phase III for plaque psoriasis and atopic dermatitis. Pipeline includes JAK1‑targeted creams for alopecia, eczema and a CD200R fusion for AD.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 342
- HQ: Westlake Village
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.